Tag Archives: GSK

Top 10 Casino Stocks To Watch For 2019

Michael E. Lewitt

Back in April, I recommended Caesars Entertainment Corp. (Nasdaq: CZR) as a buy – but warned you that this was a play that might take some time to mature.

If you haven’t gotten in already, you’ll want to do it soon.

After months of bitter wrangling, the much-beleaguered Caesars has finally reached a $5 billion deal with the private-equity sponsors that looted the company, Apollo Global Management, LLC (NYSE: APO) and TPG Capital (formerly Texas Pacific Group). Pending approval by the U.S. Bankruptcy Court in Chicago, CZR is now set to leave bankruptcy, get rid of its debt, and get back on its feet.

Of course, this means very good news for stockholders (like you, I hope).

Here’s why you can expect to start seeing profits…

CZR’s Bonds Are Recovering – and Its Stock Will, Too

The sad chapter of Caesars Entertainment’s ownership by these two private-equity firms appears to be mercifully coming to an end. The firms agreed to increase their offer to repay the creditors some (but not all) of the billions of dollars they looted from the company in a desperate and disgusting effort to save their ill-fated investment in the casino giant. While they will retain an equity interest in the company, a majority of the stock will be held by the creditors who suffered at their hands.

Top 10 Casino Stocks To Watch For 2019: Telefonica Brasil S.A.(VIV)

Advisors’ Opinion:

  • [By Paul Ausick]

    Telefônica Brasil SA (NYSE: VIV) dropped about 2.3% Wednesday to set a new 52-week low of $9.72. Shares closed at $9.95 on Tuesday and the stock’s 52-week high is $17.33. Volume totaled around 1.4 million, about 25% below the daily average. The company had no specific news.

  • [By Ethan Ryder]

    Windstream (NASDAQ: WIN) and Telefonica Brasil (NYSE:VIV) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

  • [By Max Byerly]

    Vivendi (EPA:VIV) received a €23.50 ($27.33) price target from stock analysts at Barclays in a research note issued on Friday. The brokerage currently has a “neutral” rating on the stock.

  • [By Ethan Ryder]

    UBS Group set a €25.50 ($29.65) target price on Vivendi (EPA:VIV) in a research note issued to investors on Friday morning, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.

Top 10 Casino Stocks To Watch For 2019: Enduro Royalty Trust(NDRO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Enduro Royalty Trust (NDRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Enduro Royalty Trust (NDRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

Top 10 Casino Stocks To Watch For 2019: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

    Get Vistagen Therapeutics alerts:

    Investor’s Alert (Earnings Per Share) – VistaGen Therapeutics Inc (NASDAQ: VTGN) (stocksmarketcap.com) Stock Technical’s & Performances to Explore – VistaGen Therapeutics Inc (NASDAQ: VTGN) (stockspen.com) US STOCKS ON THE MOVE-Media and telecom stocks, H & R Block, TAL Education (nasdaq.com) Tracking the HMA Level on These Shares: VistaGen Therapeutics, Inc. (:VTGN): HMA Reading 1.4214792 (stocknewscaller.com) Keep Your Eyes on Hot Stock of Yesterday— VistaGen Therapeutics, Inc. (VTGN) (stockmarketstop.com)

    Vistagen Therapeutics traded down $0.02, reaching $1.46, on Tuesday, according to MarketBeat Ratings. The company’s stock had a trading volume of 2,930 shares, compared to its average volume of 2,201,613. The stock has a market cap of $34.35 million, a P/E ratio of -0.95 and a beta of 0.29. Vistagen Therapeutics has a 52 week low of $0.69 and a 52 week high of $2.65.

  • [By Ethan Ryder]

    Vistagen Therapeutics (NASDAQ:VTGN) was given a $6.00 price target by analysts at Oppenheimer Holdings Inc.. The firm currently has a buy rating on the stock.

  • [By Money Morning News Team]

    While exciting, CODX and our other penny stocks to watch this week are unlikely to tack on any additional gains this week. But don’t worry. After looking at our 10 top penny stocks to watch, we’ll show you a stock with serious profit potential in its future…

    Penny Stock Current Share Price Last Week’s Gain
    Co-Diagnostics Inc. (Nasdaq: CODX)  $4.35 192.07%
    Viking Therapeutics Inc. (Nasdaq: VKTX)  $9.37 95.78%
    DHI Group Inc. (NYSE: DHX)  $3.10 67.57%
    Axovant Sciences Ltd. (Nasdaq: AXON)  $1.76 60.00%
    Netlist Inc. (Nasdaq: NLST)  $0.21 53.79%
    Link Motion Inc. (NYSE LKM)  $1.23 47.73%
    CorMedix Inc. (NYSE: CRMD)  $0.26 44.44%
    Vistagen Therapeutics Inc. (Nasdaq: VTGN)  $1.34 40.21%
    J. Jill Inc. (NYSE: JILL)  $8.30 36.55%
    Adomani Inc. (Nasdaq: ADOM)  $1.52 34.86%

    In order to make sure we protect ourselves from any substantial losses from investing in penny stocks, we follow five rules for penny stock investing. Take look at them on the right.As these stocks demonstrate, there are penny stocks that have tremendous growth potential that can easily dwarf your initial investment. However, most penny stocks lack the solid underlying financials necessary to generate a significant return.
    Fast Money: This powerful secret made one man a millionaire. Now he’s sharing it live on camera – find out how you could use it to become $2,918 richer in less than a minute. Click here…

Top 10 Casino Stocks To Watch For 2019: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cryptosolartech (CURRENCY:CST) traded up 4.2% against the dollar during the 1-day period ending at 20:00 PM ET on October 6th. One Cryptosolartech token can now be purchased for approximately $0.0203 or 0.00000309 BTC on exchanges. Cryptosolartech has a total market capitalization of $1.30 million and approximately $247,044.00 worth of Cryptosolartech was traded on exchanges in the last 24 hours. During the last seven days, Cryptosolartech has traded 4.1% lower against the dollar.

Top 10 Casino Stocks To Watch For 2019: Gold Standard Ventures Corporation(GSV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Gold Standard Ventures Corp (NYSEAMERICAN:GSV) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 6,511,796 shares, a drop of 7.7% from the April 30th total of 7,056,069 shares. Based on an average daily volume of 268,131 shares, the short-interest ratio is currently 24.3 days. Approximately 5.9% of the company’s stock are sold short.

Top 10 Casino Stocks To Watch For 2019: Templeton Dragon Fund Inc.(TDF)

Advisors’ Opinion:

  • [By Logan Wallace]

    News articles about Templeton Dragon Fund Inc common stock (NYSE:TDF) have trended somewhat positive on Sunday, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Templeton Dragon Fund Inc common stock earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the financial services provider an impact score of 45.9946586007156 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Templeton Dragon Fund Inc common stock (NYSE:TDF) major shareholder City Of London Investment Grou bought 8,155 shares of the company’s stock in a transaction that occurred on Tuesday, June 12th. The shares were purchased at an average price of $22.87 per share, with a total value of $186,504.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Top 10 Casino Stocks To Watch For 2019: Applied Materials, Inc.(AMAT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Applied Materials Inc. (NASDAQ: AMAT) dropped about 5.3% Thursday to set a new 52-week low of $40.25. Shares closed at $42.50 on Wednesday and the stock’s 52-week high is $62.40. Volume totaled around 19million, about 40% below the daily average. The semiconductor equipment maker is turning into an over-priced house in a declining neighborhood.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Applied Materials (AMAT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Short interest in Applied Materials Inc. (NASDAQ: AMAT) decreased to 13.87 million shares. The previous reading was 16.51 million. Shares were trading at $39.19, in a 52-week range of $28.79 to $62.40.

  • [By Nicholas Rossolillo]

    That could cause anxiety, but it also spells opportunity for investors looking for a deal. Even the high-flying tech sector sports some real bargains these days. Three worth your consideration are Applied Materials (NASDAQ:AMAT), Micron Technology (NASDAQ:MU), and Vodafone (NASDAQ:VOD).

  • [By Ashraf Eassa]

    Although TSMC is an obvious beneficiary from the production of the A12 chip, there’s another company that’s poised to profit handsomely as Apple and other companies start building chips using TSMC’s (as well as other companies’) 7nm technologies: Applied Materials (NASDAQ:AMAT).

  • [By Jon C. Ogg]

    Applied Materials Inc. (NASDAQ: AMAT) typically has beaten its earnings and sales expectations. Apparently, the top U.S. player for semiconductor capital equipment is finding out that 29% in quarterly revenue growth (to $4.57 billion) and a 54% jump in operating income (to $1.22 per share) from a year ago aren’t enough in the face of expectations ahead.

Top 10 Casino Stocks To Watch For 2019: Xerium Technologies Inc.(XRM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Xerium Technologies (NYSE:XRM) has trended somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Xerium Technologies earned a news impact score of 0.17 on Accern’s scale. Accern also assigned press coverage about the industrial products company an impact score of 47.7306467260184 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Casino Stocks To Watch For 2019: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    GlaxoSmithKline plc (NYSE:GSK) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 8,497,397 shares, a drop of 27.2% from the May 15th total of 11,675,520 shares. Based on an average daily volume of 2,406,543 shares, the short-interest ratio is currently 3.5 days.

  • [By Shane Hupp]

    Dean Capital Investments Management LLC acquired a new stake in GlaxoSmithKline plc (NYSE:GSK) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 20,362 shares of the pharmaceutical company’s stock, valued at approximately $821,000. GlaxoSmithKline comprises about 0.5% of Dean Capital Investments Management LLC’s portfolio, making the stock its 15th largest position.

  • [By Todd Campbell]

    Following the sharp sell-off in Sangamo’s shares, Lanphier agreed to step down as Sangamo’s CEO in June 2016. In his place, Sangamo’s board of directors hired Sandy Macrae, a GlaxoSmithKline (NYSE:GSK) veteran who had most recently been the global medical officer for Takeda Pharmaceuticals.

  • [By Chris Lange]

    GlaxoSmithKline PLC (NYSE: GSK) has a meeting with the FDA’s Pulmonary-Allergy Drugs Advisory Committee scheduled for July 25. The meeting is in regards to the firm’s supplementary Biologics License Agreement (sBLA) for its chronic obstructive pulmonary disease (COPD) treatment, mepolizumab.

  • [By George Budwell]

    As the company didn’t release any major clinical or regulatory news last month, Agenus’ shares appear to have gotten a boost mainly from the stronger-than-expected launch of GlaxoSmithKline’s (NYSE:GSK) shingles vaccine Shingrix.

Top 10 Casino Stocks To Watch For 2019: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Logan Wallace]

    News stories about Lightinthebox (NYSE:LITB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Lightinthebox earned a daily sentiment score of 0.04 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 46.3507616645709 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Casino Stocks To Buy Right Now

Monarch Casino & Resort (NASDAQ:MCRI) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Tuesday.

Several other research analysts also recently issued reports on MCRI. Jefferies Financial Group raised Monarch Casino & Resort from an “underperform” rating to a “hold” rating and set a $48.00 price objective for the company in a research note on Wednesday, July 25th. Stifel Nicolaus increased their target price on shares of Monarch Casino & Resort from $45.00 to $49.00 and gave the company a “hold” rating in a research report on Wednesday, July 25th. Finally, Zacks Investment Research raised shares of Monarch Casino & Resort from a “hold” rating to a “buy” rating and set a $53.00 target price for the company in a research report on Friday, July 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. Monarch Casino & Resort currently has an average rating of “Hold” and a consensus price target of $50.00.

Top 10 Casino Stocks To Buy Right Now: athenahealth, Inc.(ATHN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get athenahealth alerts:

    athenahealth (ATHN) Up 2.6% Since Last Earnings Report: Can It Continue? (finance.yahoo.com) athenahealth, Inc (ATHN) Receives Average Recommendation of “Hold” from Brokerages (americanbankingnews.com) Contrasting Global Payments (GPN) and athenahealth (ATHN) (americanbankingnews.com) Brokerages Anticipate athenahealth, Inc (ATHN) Will Announce Quarterly Sales of $336.41 Million (americanbankingnews.com) M&A chatter has athenahealth moving on heavy volume (seekingalpha.com)

    ATHN opened at $153.90 on Tuesday. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $6.23 billion, a price-to-earnings ratio of 98.03, a PEG ratio of 2.71 and a beta of 0.95. athenahealth has a twelve month low of $111.61 and a twelve month high of $163.94.

  • [By Logan Wallace]

    athenahealth (NASDAQ:ATHN) SVP Jonathan D. Porter sold 150 shares of athenahealth stock in a transaction dated Tuesday, May 29th. The shares were sold at an average price of $152.61, for a total value of $22,891.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

  • [By ]

    It provides cloud-based software to healthcare companies. And it has a track record of strong revenue and earnings growth. Which company is it? Veeva Systems (NYSE:VEEV) is a correct answer. So is athenahealth (NASDAQ:ATHN).  

  • [By Stephan Byrd]

    athenahealth, Inc (NASDAQ:ATHN) insider Daniel P. Haley sold 2,204 shares of the stock in a transaction on Monday, October 1st. The shares were sold at an average price of $127.23, for a total value of $280,414.92. Following the completion of the transaction, the insider now directly owns 10,555 shares of the company’s stock, valued at $1,342,912.65. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Top 10 Casino Stocks To Buy Right Now: Unifi, Inc.(UFI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Unifi, Inc. (NYSE:UFI) Director Robert J. Bishop purchased 4,000 shares of Unifi stock in a transaction dated Friday, August 31st. The stock was bought at an average price of $31.79 per share, with a total value of $127,160.00. Following the completion of the purchase, the director now directly owns 10,288 shares of the company’s stock, valued at $327,055.52. The purchase was disclosed in a legal filing with the SEC, which is available through this link.

Top 10 Casino Stocks To Buy Right Now: EP Energy Corporation(EPE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Enterprise GP Holdings L.P. (NYSE:EPE) shares were up 5.5% during trading on Wednesday . The stock traded as high as $2.55 and last traded at $2.51. Approximately 939,243 shares traded hands during mid-day trading, a decline of 13% from the average daily volume of 1,077,065 shares. The stock had previously closed at $2.38.

  • [By Money Morning News Team]

    And after taking a look at our 10 top penny stocks to watch, we’ll show you a small-cap stock that just signed a deal with Facebook Inc. (Nasdaq: FB)…

    Penny Stock Current Share Price Law Week’s Gain
    Blink Charging Co. (Nasdaq: BLNK) $6.00 288.51%
    Enterprise GP Holdings LP (NYSE: EPE) $2.94 44.00%
    Opko Health Inc. (Nasdaq: OPK) $4.79 43.49%
    MYnd Analytics Inc. (Nasdaq: MYND) $3.15 38.84%
    Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) $0.52 37.80%
    Mid-Con Energy Partners LP (Nasdaq: MCEP) $2.08 36.81%
    VAALCO Energy (NYSE: EGY) $1.49 36.04%
    Cel-Sci Corp. (NYSE: CVM) $3.16 35.04%
    WideOpenWest Inc. (NYSE: WOW) $8.41 34.52%
    Legacy Reserves LP (Nasdaq: LGCY) $8.43 33.61%

    While these gains are certainly exciting, it’s important to recognize that investing in penny stocks is also a risky investment strategy.

  • [By Logan Wallace]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Enterprise GP Holdings L.P. common stock alerts:

    Enterprise GP Holdings L.P. common stock (EPE) Receives Average Recommendation of “Hold” from Analysts (americanbankingnews.com) $314.69 Million in Sales Expected for Enterprise GP Holdings L.P. common stock (EPE) This Quarter (americanbankingnews.com) Enterprise GP Holdings L.P. common stock (EPE) Major Shareholder Sells $707,974.10 in Stock (americanbankingnews.com) Today’s Free Research Reports Coverage on Jones Energy and Three More Independent Oil & Gas Stocks (finance.yahoo.com) Research Analysts Offer Predictions for Enterprise GP Holdings L.P. common stock’s Q2 2018 Earnings (EPE) (americanbankingnews.com)

    Several research firms recently weighed in on EPE. Zacks Investment Research raised Enterprise GP Holdings L.P. common stock from a “hold” rating to a “buy” rating and set a $3.50 price target on the stock in a research report on Thursday, June 21st. ValuEngine lowered Enterprise GP Holdings L.P. common stock from a “buy” rating to a “hold” rating in a research report on Friday, June 15th. Stifel Nicolaus set a $3.00 price target on Enterprise GP Holdings L.P. common stock and gave the stock a “hold” rating in a research note on Monday, April 23rd. KLR Group downgraded Enterprise GP Holdings L.P. common stock from a “buy” rating to a “hold” rating and set a $3.00 price target for the company. in a research note on Monday, May 14th. Finally, Wells Fargo & Co decreased their price target on Enterprise GP Holdings L.P. common stock from $3.00 to $2.00 and set a “market perform” rating for the company in a research note on Monday, March 19th. Five analysts have rated the stock with a sell rating, nine have given a hold rating and two have give

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enterprise GP (EPE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)

Top 10 Casino Stocks To Buy Right Now: SPDR S&P 500 ETF (SPY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    HL Financial Services LLC boosted its position in shares of SPDR S&P 500 ETF Trust (NYSEARCA:SPY) by 3.7% in the second quarter, Holdings Channel reports. The institutional investor owned 43,895 shares of the company’s stock after acquiring an additional 1,569 shares during the period. HL Financial Services LLC’s holdings in SPDR S&P 500 ETF Trust were worth $11,907,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Deroy & Devereaux Private Investment Counsel Inc. reduced its stake in SPDR S&P 500 ETF Trust (NYSEARCA:SPY) by 1.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,990 shares of the company’s stock after selling 239 shares during the period. Deroy & Devereaux Private Investment Counsel Inc.’s holdings in SPDR S&P 500 ETF Trust were worth $3,795,000 at the end of the most recent quarter.

  • [By Wayne Duggan]

    Investors are clearly concerned with a potential breakdown in trade negotiations. The SPDR Dow Jones Industrial Average ETF (NYSE: SPY) is down 0.6 percent in the past two days, and the iShares FTSE/Xinhua China 25 Index (ETF) (NYSE: FXI) is down 2 percent.

  • [By Shane Hupp]

    Fayez Sarofim & Co reduced its stake in shares of SPDR S&P 500 ETF Trust (NYSEARCA:SPY) by 67.4% during the first quarter, HoldingsChannel reports. The firm owned 800 shares of the company’s stock after selling 1,654 shares during the period. Fayez Sarofim & Co’s holdings in SPDR S&P 500 ETF Trust were worth $211,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Max Byerly]

    Jackson Wealth Management LLC acquired a new stake in shares of SPDR S&P 500 ETF Trust (NYSEARCA:SPY) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 11,767 shares of the company’s stock, valued at approximately $3,342,000.

  • [By Javier Hasse]

    The Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF) tumbled 1.7 percent over the five days of the week, while the ETFMG Alternative Harvest ETF (NYSE: MJ) lost 1.8 percent. The SPDR S&P 500 ETF Trust (NYSE: SPY) gained 0.3 percent.

Top 10 Casino Stocks To Buy Right Now: PriceSmart, Inc.(PSMT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on PriceSmart (PSMT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Demitrios Kalogeropoulos]

    International warehouse club PriceSmart (NASDAQ:PSMT) has seen its fortunes improve recently as economic growth rates steadied in many of its core Latin American, Caribbean, and Central American markets. The retailer is also benefiting from a sharp rebound in the value of the local Colombian currency.

  • [By Demitrios Kalogeropoulos]

    The week ahead is shortened by the July 4 holiday, but still includes a few big-name earnings reports that could move individual stocks. Below, we’ll preview what investors will be focusing on with these announcements from Herman Miller (NASDAQ:MLHR), Acuity Brands (NYSE:AYI), and PriceSmart (NASDAQ:PSMT).

  • [By Chris Lange]

    When PriceSmart Inc. (NASDAQ: PSMT) released its fiscal third-quarter financial results late on Thursday, the company said that it had $0.61 in earnings per share (EPS) and $782.2 million in revenue. Consensus estimates had called for $0.63 in EPS and $777.1 million in revenue. The same period of last year reportedly had EPS of $0.62 and $730.3 million in revenue.

Top 10 Casino Stocks To Buy Right Now: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    TRADEMARK VIOLATION NOTICE: “GlaxoSmithKline plc (GSK) Shares Bought by Usca Ria LLC” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4196137/glaxosmithkline-plc-gsk-shares-bought-by-usca-ria-llc.html.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    Unlike most drug developers, Innoviva is a royalty-based company. Having spun off Theravance BioPharma years ago, Innoviva now sits back and collects royalties on the net sales of long-lasting COPD and asthma therapies jointly developed with GlaxoSmithKline (NYSE:GSK). You probably know these drugs as Breo Ellipta, Anoro Ellipta, and the newly approved Trelegy Ellipta.

  • [By Sean Williams]

    Lastly, there’s Innoviva (NASDAQ:INVA), which isn’t a traditional drug stock, per se. Innoviva is a royalty company that’s currently reaping benefits from a group of long-lasting COPD and asthma medications that were developed in cooperation with GlaxoSmithKline (NYSE:GSK). You know these medicines today as Breo Ellipta and Anoro Ellipta, to name a few.

Top 10 Casino Stocks To Buy Right Now: CytomX Therapeutics, Inc.(CTMX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on CytomX Therapeutics (CTMX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of CytomX Therapeutics Inc (NASDAQ:CTMX) have been given a consensus recommendation of “Buy” by the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $38.33.

  • [By Chris Lange]

    CytomX Therapeutics Inc. (NASDAQ: CTMX) is presenting on a couple different topics: probody conjugate (CX-2009) treatment in patients with advanced solid tumors and probody drug conjugate targeting CD166 in preclinical antitumor activity. Wedbush has an Outperform rating with a price target of $25, implying upside of 123% from Friday’s closing price of $11.22. The shares have a 52-week range of $10.91 to $35.00. The stock has a consensus price target of $29.20.

  • [By Ethan Ryder]

    CytomX Therapeutics Inc (NASDAQ:CTMX) – Stock analysts at Jefferies Financial Group issued their Q3 2018 EPS estimates for shares of CytomX Therapeutics in a research report issued on Wednesday, August 8th. Jefferies Financial Group analyst B. Amin expects that the biotechnology company will post earnings per share of ($0.57) for the quarter. Jefferies Financial Group also issued estimates for CytomX Therapeutics’ Q4 2018 earnings at ($0.64) EPS, FY2018 earnings at ($1.98) EPS, FY2019 earnings at ($2.73) EPS, FY2020 earnings at ($3.12) EPS, FY2021 earnings at ($3.27) EPS and FY2022 earnings at ($3.33) EPS.

  • [By Lisa Levin] Gainers
    Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
    CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
    Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
    Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
    Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
    Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
    Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
    Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
    Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

     

  • [By Joseph Griffin]

    Shares of CytomX Therapeutics Inc (NASDAQ:CTMX) have been assigned an average rating of “Buy” from the twelve analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $39.86.

Top 10 Casino Stocks To Buy Right Now: Hot Tech Stocks To Own For 20()

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get CBRE Group alerts:

    Parmer Innovation Center to become mammoth employment hub in Northeast Austin (bizjournals.com) Rockefeller leases 138,000 s/f to Blank Rome (rew-online.com) CBRE Group CEO expects another year of double-digit earnings growth (smartbrief.com) Contrasting CBRE Group (CBRE) and Colliers International Gr (CIGI) (americanbankingnews.com) Scanning the CBRE Group, Inc. (:CBRE) Charts – What’s Next For the Shares? (derbynewsjournal.com)

    CBRE Group remained flat at $$47.42 during trading on Thursday, according to Marketbeat Ratings. The company’s stock had a trading volume of 1,305,500 shares, compared to its average volume of 2,132,441. The company has a market cap of $15.94 billion, a PE ratio of 17.50, a price-to-earnings-growth ratio of 1.16 and a beta of 1.70. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.18 and a quick ratio of 1.18. CBRE Group has a 12-month low of $46.79 and a 12-month high of $47.41.

  • [By ]

    For example, say “Remind my wife about the party and say don’t forget to pick up a bottle of red wine tonight.” Siri will know who your spouse is (or will ask you once) and place that in the To: field, and because you said “about” the party, Siri knows you want that in the Subject (Re:) field. You also said “and say,” which places words you said after that into the body of the email. This will all save you time!

  • [By Ethan Ryder]

    Canaccord Genuity (:) has been given an average recommendation of “N/A” by the zero brokerages that are currently covering the company, Marketbeat reports.

  • [By Max Byerly]

    (CURRENCY:) traded flat against the US dollar during the 24 hour period ending at 8:00 AM E.T. on April 18th. In the last seven days, has traded flat against the US dollar. One coin can currently be purchased for about $0.0000 or 0.00000000 BTC on exchanges including 295

  • [By Logan Wallace]

    window._wpemojiSettings = {“baseUrl”:”https://s.w.org/images/core/emoji/2.4/72×72/”,”ext”:”.png”,”svgUrl”:”https://s.w.org/images/core/emoji/2.4/svg/”,”svgExt”:”.svg”,”source”:{“concatemoji”:”https://ledgergazette.com/wp-includes/js/wp-emoji-release.min.js?ver=4.9.7″}};
    !function(a,b,c){function d(a,b){var c=String.fromCharCode;l.clearRect(0,0,k.width,k.height),l.fillText(c.apply(this,a),0,0);var d=k.toDataURL();l.clearRect(0,0,k.width,k.height),l.fillText(c.apply(this,b),0,0);var e=k.toDataURL();return d===e}function e(a){var b;if(!l||!l.fillText)return!1;switch(l.textBaseline=”top”,l.font=”600 32px Arial”,a){case”flag”:return!(b=d([55356,56826,55356,56819],[55356,56826,8203,55356,56819]))&&(b=d([55356,57332,56128,56423,56128,56418,56128,56421,56128,56430,56128,56423,56128,56447],[55356,57332,8203,56128,56423,8203,56128,56418,8203,56128,56421,8203,56128,56430,8203,56128,56423,8203,56128,56447]),!b);case”emoji”:return b=d([55357,56692,8205,9792,65039],[55357,56692,8203,9792,65039]),!b}return!1}function f(a){var c=b.createElement(“script”);c.src=a,c.defer=c.type=”text/javascript”,b.getElementsByTagName(“head”)[0].appendChild(c)}var g,h,i,j,k=b.createElement(“canvas”),l=k.getContext&&k.getContext(“2d”);for(j=Array(“flag”,”emoji”),c.supports={everything:!0,everythingExceptFlag:!0},i=0;i .copyrights {background-color:#FFFFFF;}

  • [By ]

    Thurs., March 7, 2019: 📌National Cereal Day Be Heard Day Crown Roast of Pork Day Nametag Day Plant Power Day (UK) University Mental Health Day (UK) World Book Day (UK) 📚❤ ✔Thursday celebrates the breakfast food that works well as a midnight snack 🙂 In fact, a U.S. study found 56% of millennials eat it as a snack.🥣 🥣 🥣 •Top 3 bestsellers in the US: Honey Nut Cheerios, Cheerios, and Kelloggs Frosted Flakes. •Desserts pretending to be cereals🤣🤣🤣: Lucky Charms, Cocoa Puffs, Cookie Crisp, Fruity Pebbles, Oreo O’s, Reese’s Puffs, Fruit Loops, Cap’n Crunch, Cinnamon Toast Crunch.😋 📸:@foodieproblemz

Top 10 Casino Stocks To Buy Right Now: PowerShares S&P SmallCap Consumer Discretionary Portfolio(PSCD)

Advisors’ Opinion:

  • [By Max Byerly]

    Wells Fargo & Company MN raised its holdings in shares of Invesco S&P SmallCap Consumer Discretionary ETF (NASDAQ:PSCD) by 0.9% during the second quarter, HoldingsChannel reports. The firm owned 815,500 shares of the company’s stock after buying an additional 6,884 shares during the period. Wells Fargo & Company MN owned 0.47% of Invesco S&P SmallCap Consumer Discretionary ETF worth $53,700,000 as of its most recent SEC filing.

Top 10 Casino Stocks To Buy Right Now: Codorus Valley Bancorp, Inc(CVLY)

Advisors’ Opinion:

  • [By Logan Wallace]

    Codorus Valley Bancorp, Inc. (NASDAQ:CVLY) declared a quarterly dividend on Tuesday, July 10th, NASDAQ reports. Investors of record on Tuesday, July 24th will be given a dividend of 0.155 per share by the financial services provider on Tuesday, August 14th. This represents a $0.62 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date of this dividend is Monday, July 23rd.

  • [By Logan Wallace]

    Codorus Valley Bancorp (NASDAQ:CVLY) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Friday.

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Codorus Valley Bancorp (NASDAQ:CVLY) from a buy rating to a hold rating in a research note released on Thursday morning.

Best Warren Buffett Stocks To Buy For 2019

Apple, which already held the crown as the nation’s most-valuable company, made Wall Street history Thursday when it became the first publicly traded U.S. corporation to reach a market value of $1 trillion.

Apple, whose stock is owned by investors ranging from billionaire Warren Buffett to mutual fund giant Vanguard to millions of working Americans through funds owned in their 401(k)s, passed the milestone days after reporting another stellar quarter, highlighted by a jump in revenue to $53.3 billion and the sale of 41.3 million iPhones.

The iPhone maker broke the $1 trillion barrier when its stock briefly hit the magic share price of $207.05, according to Nanex, which supplies market data to the financial industry. Online brokerage TD Ameritrade said the history-making trade occurred at 11:48 a.m. ET.

Best Warren Buffett Stocks To Buy For 2019: First Horizon National Corporation(FHN)

Advisors’ Opinion:

  • [By Logan Wallace]

    First Horizon National (NYSE:FHN) will be posting its quarterly earnings results before the market opens on Thursday, July 12th.

    First Horizon National (NYSE:FHN) last posted its earnings results on Friday, April 13th. The financial services provider reported $0.34 EPS for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.04. First Horizon National had a return on equity of 9.37% and a net margin of 12.30%. The business had revenue of $437.20 million for the quarter, compared to analysts’ expectations of $438.60 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The business’s revenue was up 42.6% compared to the same quarter last year. On average, analysts expect First Horizon National to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

  • [By Joseph Griffin]

    Cadence Capital Management LLC boosted its holdings in First Horizon National Corp (NYSE:FHN) by 173.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,515 shares of the financial services provider’s stock after buying an additional 19,357 shares during the quarter. Cadence Capital Management LLC’s holdings in First Horizon National were worth $544,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Brown Advisory Inc. grew its holdings in First Horizon National Corp (NYSE:FHN) by 117.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 65,240 shares of the financial services provider’s stock after acquiring an additional 35,197 shares during the quarter. Brown Advisory Inc.’s holdings in First Horizon National were worth $1,164,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By ]

    In an “Executive Decision” segment, Cramer sat down with Bryan Jordan, chairman, president and CEO of First Horizon National (FHN) , the Tennessee-based regional bank that just posted a three-cents-a-share earnings beat with net interest margins up 52 basis points.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on First Horizon National (FHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Warren Buffett Stocks To Buy For 2019: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Keith Speights]

    It’s been a very different year so far for two big pharma stocks: One’s hot and one’s not. Things are going great for GlaxoSmithKline plc (NYSE:GSK) as its share price is up around 15% year to date. But for Johnson & Johnson (NYSE:JNJ), it’s a different story. J&J stock is down more than 10% in 2018.

  • [By George Budwell]

    After a prolonged downturn, British pharma goliath GlaxoSmithKline (NYSE:GSK) has finally started to recapture the imagination of Wall Street. The overwhelming majority of analysts covering the stock, for instance, have a favorable rating on Glaxo’s shares right now, and large institutional investors have been slowly upping their positions in this downtrodden big pharma equity in recent quarters.    

  • [By Chris Lange]

    GlaxoSmithKline PLC (NYSE: GSK) has a meeting with the FDA’s Pulmonary-Allergy Drugs Advisory Committee scheduled for July 25. The meeting is in regards to the firm’s supplementary Biologics License Agreement (sBLA) for its chronic obstructive pulmonary disease (COPD) treatment, mepolizumab.

  • [By ]

    HSBC’s top stocks list is mostly dominated by large-cap plays that happen to pay attractive dividend yields. More importantly, the stocks already have a decent amount of momentum behind them: the average one-month performance is +5.5%. 

    Baker Hughes (BHGE) Tiffany & Co. (TIF) The Mosaic Company (MOS) Deutsche Telekom Schneider Electric Adidas (ADDYY) Unicredit  CRH (CRH) Luftansa  GlaxosmithKline (GSK) Associated British Foods   Fresnillo China Construction Bank China Overseas Land & Inv. Geely Automobile Holdings CRCC China Resources Beer Samsung Electronic Sasol Adani Ports and SEZ

  • [By Keith Speights]

    GlaxoSmithKline (GSK), like Teva, lost ground last year, with its stock declining by nearly 8%. So far in 2018, though, GSK’s share price is up more than 12% — trouncing the major indexes.

Best Warren Buffett Stocks To Buy For 2019: TransAct Technologies Incorporated(TACT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on TransAct Technologies (TACT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Logitech (NASDAQ: LOGI) and TransAct Technologies (NASDAQ:TACT) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on TransAct Technologies (TACT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    TransAct Technologies Incorporated (NASDAQ:TACT) Chairman Bart C. Shuldman sold 1,272 shares of TransAct Technologies stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $14.35, for a total value of $18,253.20. Following the completion of the transaction, the chairman now directly owns 18,205 shares in the company, valued at approximately $261,241.75. The sale was disclosed in a document filed with the SEC, which is available at this link.

Best Warren Buffett Stocks To Buy For 2019: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Brian Orelli]

    The phase 2 TOPACIO/Keynote-162 trial tests Tesaro’s (NASDAQ:TSRO) poly (ADP-ribose) polymerase (PARP) inhibitor, Zejula, with Keytruda. On Sunday, outcomes for patients with recurrent ovarian cancer will be presented, as Tesaro and Merck look to build on earlier promising results. Then on Monday, the duo will present data testing the combination in patients with metastatic triple-negative breast cancer as Tesaro looks to expand the market for Zejula.

  • [By Cory Renauer]

    All of these biotech stocks have been battered for different reasons, and bouncing back will be a lot easier for some than for others. 

    Company (Symbol) One-Month Loss  Market Capitalization
    Idera Pharmaceuticals (NASDAQ:IDRA) (35%) $199.7 million
    Spark Therapeutics (NASDAQ:ONCE) (38%) $2.16 billion
    Tesaro (NASDAQ:TSRO) (40%) $1.49 billion

    Here’s what needs to happen if these stocks are going to mount a comeback.

  • [By Todd Campbell]

    Tesaro, Inc. (NASDAQ:TSRO) shares are rallying this week on rumors it’s an acquisition target. The company, which markets two cancer drugs, recently increased its sales guidance because of growing demand. Given that shares are trading at a steep discount to where they were last year, it could be the perfect time for a suitor to come knocking. Here’s what investors should know about this company and why it could be attractive to a buyer.

  • [By Paul Ausick]

    Tesaro Inc. (NASDAQ: TSRO) traded down about 10% Tuesday and posted a new 52-week low of $74.57 after Friday at $82.87. The 52-week high is $192.94. Volume was about 2 million, more than double the daily average of around 870,000 million shares. The maker of cancer therapeutics had no specific news.

Top 10 Casino Stocks To Watch Right Now

“Real estate is an imperishable asset ever increasing in value. It is the most solid security that human ingenuity has devised.” — Russell Sage

Walt Disney (1901-66), the singular visionary genius who — more than anyone — transformed the business of entertainment in the 20th century, had legions of admirers over the decades. Among them is Steve Wynn, founder, CEO and guiding mastermind of his eponymous casino empire. In both public and private statements, Wynn has pointed to Disney’s core insight into the fine art of delighting consumers as what drives the management culture of his company until this day.

But for all his prescient brilliance, Disney did not fully apprehend the shower of millions his Disneyland theme park would have on the properties surrounding the Anaheim project. Neither did the very savvy Harrison Price of the Stamford Research Institute, who Disney commissioned to pick out the best possible location for his first theme park.

He acquired 160 acres of orange groves and walnut trees in the then-sleepy Orange County suburb of Anaheim, believing it would provide a huge enough footprint upon which to build his dream. And it did. What he didn’t really grasp was that the nearby land could still be picked up cheap if you were either a speculator or a motel company foreseeing more than day-trippers visiting the park. As a result, no sooner than Disneyland opened in July 1955 was the area blotted with construction projects for motels, hotels, restaurants and shopping centers whose primary claim to financial viability sprung from their proximity to Disneyland. Walt watched the parasite property owners grow rich and vowed never to repeat the mistake. And he didn’t.

Top 10 Casino Stocks To Watch Right Now: NetApp Inc.(NTAP)

Advisors’ Opinion:

  • [By Taylor Cox]

    Notable Earnings

    Tiffany & Co. (NYSE: TIF) Q1 premarket
    Ralph Lauren Corporation (NYSE: RL) Q4 premarket
    Target Corporation (NYSE: TGT) Q1 premarket
    Lowe’s Companies, Inc (NYSE: LOW) Q1 premarket
    L Brands, Inc (NYSE: LB) Q1 after hours
    NetApp, Inc (NASDAQ: NTAP) Q4 after hours

    IPOs

  • [By Stephan Byrd]

    Profund Advisors LLC lifted its stake in shares of NetApp Inc. (NASDAQ:NTAP) by 14.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,660 shares of the data storage provider’s stock after purchasing an additional 1,193 shares during the period. Profund Advisors LLC’s holdings in NetApp were worth $596,000 at the end of the most recent quarter.

  • [By Jon C. Ogg]

    NetApp Inc. (NASDAQ: NTAP) was reiterated as Buy and the price target was raised to $90 from $76 at Argus. The firm noted that new offerings with Cisco in the FlexPod solutions have a big jump in health care and the firm came up with a blended analysis of earnings and valuation that could be north of $100 for the stock.

  • [By Lee Jackson]

    NetApp Inc. (NASDAQ: NTAP) was added to US 1 list earlier this yearand has been on big run since last fall.The company provides software, systems and services to manage and store computer data worldwide. It offers flash; flash arrays that support data management; hybrid arrays to deploy the speed of flash storage; hybrid cloud; ONTAP cloud storage data management service; NetApp cloud sync hybrid data management software as a service; NetApp private storage for cloud; and AltaVault cloud-integrated solutions.

Top 10 Casino Stocks To Watch Right Now: TransAct Technologies Incorporated(TACT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Logitech (NASDAQ: LOGI) and TransAct Technologies (NASDAQ:TACT) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

Top 10 Casino Stocks To Watch Right Now: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

Top 10 Casino Stocks To Watch Right Now: Perficient, Inc.(PRFT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Perficient (NASDAQ:PRFT) was downgraded by investment analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Friday.

Top 10 Casino Stocks To Watch Right Now: Cellcom Israel Ltd.(CEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

  • [By Ethan Ryder]

    Millicom (OTCMKTS: MIICF) and Cellcom Israel (NYSE:CEL) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

  • [By Lisa Levin]

    Thursday afternoon, the telecommunication services shares surged 0.58 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 5 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 2.5 percent.

Top 10 Casino Stocks To Watch Right Now: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Keith Speights]

    If you only looked at stock performance for 2018, GlaxoSmithKline plc (NYSE:GSK) would seem to be in much better shape than AbbVie Inc. (NYSE:ABBV). GSK stock is up nearly 20% year to date, while AbbVie’s share price isn’t much higher than it was at the beginning of the year. 2017 was a different story, though, with AbbVie gaining more than 50% and GSK falling 8%.

  • [By Cory Renauer]

    Around a year ago, the partners launched an eczema drug that’s already surpassed Praluent on the sales charts, and a possible expansion to asthma could send Dupixent sales through the roof.In studies supporting an application under review at the moment, Dupixent reduced severe attacks by up to 67% for some patients with uncontrolled asthma. It also led to lung function measurements that suggest it can compete with GlaxoSmithKline’s (NYSE:GSK)Nucula for a slice of a global market for asthma treatments expected to reach $56.5 billion by 2025.

  • [By Ethan Ryder]

    GlaxoSmithKline plc (NYSE:GSK) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 8,497,397 shares, a drop of 27.2% from the May 15th total of 11,675,520 shares. Based on an average daily volume of 2,406,543 shares, the short-interest ratio is currently 3.5 days.

  • [By Keith Speights]

    GlaxoSmithKline (GSK), like Teva, lost ground last year, with its stock declining by nearly 8%. So far in 2018, though, GSK’s share price is up more than 12% — trouncing the major indexes.

  • [By Sean Williams]

    Lastly, there’s Innoviva (NASDAQ:INVA), which isn’t a traditional drug stock, per se. Innoviva is a royalty company that’s currently reaping benefits from a group of long-lasting COPD and asthma medications that were developed in cooperation with GlaxoSmithKline (NYSE:GSK). You know these medicines today as Breo Ellipta and Anoro Ellipta, to name a few.

Top 10 Casino Stocks To Watch Right Now: Silicom Ltd(SILC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    F5 Networks (NASDAQ: FFIV) and Silicom (NASDAQ:SILC) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

  • [By ]

    Finally, Cramer said that Silicom (SILC) is an interesting concept with real earnings, and an attractive valuation at just 18 times earnings. However, the company is small, which mean investors need to be careful. 

Top 10 Casino Stocks To Watch Right Now: Meta Financial Group Inc.(CASH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cashcoin (CURRENCY:CASH) traded up 40.8% against the dollar during the one day period ending at 16:00 PM E.T. on May 9th. Cashcoin has a market cap of $544,583.00 and $885.00 worth of Cashcoin was traded on exchanges in the last 24 hours. Over the last seven days, Cashcoin has traded up 68.3% against the dollar. One Cashcoin coin can currently be bought for $0.0114 or 0.00000123 BTC on popular exchanges.

  • [By Shane Hupp]

    Cashcoin (CURRENCY:CASH) traded up 0.5% against the US dollar during the one day period ending at 0:00 AM E.T. on June 10th. One Cashcoin coin can currently be purchased for about $0.0079 or 0.00000117 BTC on major cryptocurrency exchanges. Over the last week, Cashcoin has traded down 29.1% against the US dollar. Cashcoin has a market capitalization of $377,649.00 and approximately $114.00 worth of Cashcoin was traded on exchanges in the last 24 hours.

  • [By Stephan Byrd]

    Meta Financial Group Inc. (NASDAQ:CASH) – Equities researchers at B. Riley cut their FY2018 earnings per share (EPS) estimates for Meta Financial Group in a report issued on Tuesday, June 19th. B. Riley analyst S. Moss now forecasts that the savings and loans company will post earnings per share of $6.43 for the year, down from their previous forecast of $6.90. B. Riley currently has a “Buy” rating and a $132.00 price target on the stock. B. Riley also issued estimates for Meta Financial Group’s Q1 2019 earnings at $1.29 EPS and Q2 2019 earnings at $3.46 EPS.

Top 10 Casino Stocks To Watch Right Now: UMH Properties Inc.(UMH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    WINTON GROUP Ltd bought a new stake in UMH PROPERTIES/SH SH (NYSE:UMH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 86,705 shares of the real estate investment trust’s stock, valued at approximately $1,163,000. WINTON GROUP Ltd owned about 0.24% of UMH PROPERTIES/SH SH as of its most recent SEC filing.

  • [By Lisa Levin]

    Wednesday afternoon, the real estate shares surged 0.56 percent. Meanwhile, top gainers in the sector included Armada Hoffler Properties, Inc. (NYSE: AHH), up 3 percent, and UMH Properties, Inc. (NYSE: UMH) up 3 percent.

Top 10 Casino Stocks To Watch Right Now: Hitachi Ltd (HTHIF)

Advisors’ Opinion:

  • [By ]

    Some of the larger companies that have begun incorporating blockchain into their industries include:

    Overstock.com (OSTK) , once a retail company, has become one of the biggest blockchain options on the stock market. The company has developed tZERO, a cryptocurrency and blockchain-based registry that complies with the regulations of the U.S. Securities & Exchange Commission. IBM (IBM) has developed blockchain technology that they are using with a large variety of partners in a large variety of industries. One example is their partnership with food retailers, most notably Walmart, to help quickly, efficiently, and securely track the supply chain to help ensure ideal food safety. They have also partnered with Maersk to work on a blockchain platform for global trade. Hitachi (HTHIF) , the Japanese conglomerate that has worked on social infrastructure and IT systems, among other industries, has begun dabbling in blockchain. It has released reports about how it believes the technology can positively impact the financial sector, and how it could potentially be used to create new services for businesses.

    There are also ETFs that one can invest in that hold a number of stocks related to blockchain. For example, the Reality Shares Nasdaq NextGen Economy ETF (BLCN) holds stocks in all of the examples above, as well as Intel (INTC) and Cisco Systems (CSCO) .

  • [By ]

    The vast dealer network, built up over the more than 90 years that Caterpillar has been in operation, is the key competitive advantage that the company possesses. While Caterpillar’s products are renowned for quality and low downtime, it is the availability of the support service on an international level in tandem with a reputation for product quality is what gives Caterpillar its edge, and has given it pole position among the world’s construction machinery manufacturers in 2017 based on construction equipment sales, outranking Komatsu Ltd. (OTCPK:KMTUF) (OTCPK:KMTUY), Hitachi Ltd. (OTCPK:HTHIF) (OTCPK:HTHIY), Volvo (OTCPK:VOLVF) (OTCPK:VOLVY), the privately-held Liebherr group, the Chinese government-owned XCMG Group, the Doosan Infracore subsidiary of the Doosan Group conglomerate, Sany (OTCPK:SNYYF) (OTC:SNYYY), and John Deere & Co.

Best Stocks To Buy Right Now

China Mobile Ltd. (NYSE: CHL) is the world’s largest mobile company. It has 900 million subscribers, almost three times the U.S. population. The company is owned by the Chinese government. The Trump administration wants to block its ability to do business in America, another casualty of an effort to keep Chinese technology companies from tapping into U.S. intellectual property.

The administration petitioned the FCC in a filing:

After significant engagement with China Mobile, concerns about increased risks to U.S. law enforcement and national security interests were unable to be resolved. Therefore, the Executive Branch of the U.S. government, through the National Telecommunications and Information Administration pursuant to its statutory responsibility to coordinate the presentation of views of the Executive Branch to the FCC, recommends that the FCC deny China Mobiles Section 214 license request.

China Mobile’s petitions to do business in the United States date back to 2013.

Best Stocks To Buy Right Now: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Cory Renauer]

    Around a year ago, the partners launched an eczema drug that’s already surpassed Praluent on the sales charts, and a possible expansion to asthma could send Dupixent sales through the roof.In studies supporting an application under review at the moment, Dupixent reduced severe attacks by up to 67% for some patients with uncontrolled asthma. It also led to lung function measurements that suggest it can compete with GlaxoSmithKline’s (NYSE:GSK)Nucula for a slice of a global market for asthma treatments expected to reach $56.5 billion by 2025.

  • [By Ethan Ryder]

    GlaxoSmithKline (NYSE:GSK) was the target of unusually large options trading on Thursday. Investors purchased 29,143 call options on the stock. This represents an increase of 938% compared to the average daily volume of 2,808 call options.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    Unlike most drug developers, Innoviva is a royalty-based company. Having spun off Theravance BioPharmayears ago, Innoviva now sits back and collects royalties on the net sales of long-lasting COPD and asthma therapies jointly developed with GlaxoSmithKline (NYSE:GSK). You probably know these drugs as Breo Ellipta, Anoro Ellipta, and the newly approved Trelegy Ellipta.

  • [By Cory Renauer]

    The fifth most valuable research and development project right now belongs to GlaxoSmithKline (NYSE:GSK) and it’s so fresh it doesn’t even have a proper name yet. GSK2857916 is a fancy protein bound to a lethal dose of chemo that it only releases when it finds its target. In this candidate’s case, the target is beta-cell maturation antigen, a protein often found on the surface of cancer cells in people with multiple myeloma.

  • [By Keith Speights]

    It’s been a very different year so far for two big pharma stocks: One’s hot and one’s not. Things are going great for GlaxoSmithKline plc(NYSE:GSK)as its share price is up around 15% year to date. But for Johnson & Johnson (NYSE:JNJ), it’s a different story. J&J stock is down more than 10% in 2018.

  • [By Keith Speights]

    GlaxoSmithKline (GSK), like Teva, lost ground last year, with its stock declining by nearly 8%. So far in 2018, though, GSK’s share price is up more than 12% — trouncing the major indexes.

Best Stocks To Buy Right Now: Akorn, Inc.(AKRX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Akorn Inc. (NASDAQ: AKRX) dropped nearly 40% Tuesday to post a new 52-week low of $18.20. Shares closed at $30.28 on Monday and the stock’s 52-week high is $34.00. Volume was nearly 22 million, more than 20 times the daily average. A potential acquirer has announced an investigation into possible data breaches. 247wallst.com/healthcare-business/2018/02/27/could-data-breaches-break-up-the-akorn-aquisition/

  • [By Joseph Griffin]

    Akorn (NASDAQ:AKRX) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Monday.

  • [By Chris Lange]

    Akorn Inc. (NASDAQ: AKRX) shares were crushed on Monday (although not as bad as at Prothena)after it was announced that the German firm Fresenius would no longer be purchasing Akorn. Fresenius noted that this was the result of alleged breaches and data integrity requirements. However, Akorn intends to fight this, but who will win is still yet to be seen.

Best Stocks To Buy Right Now: H&R Block, Inc.(HRB)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    The week ahead will likely bring more volatility, particularly for shareholders ofDave & Buster’s(NASDAQ:PLAY), H&R Block(NYSE:HRB), and Michaels(NASDAQ:MIK)as each of these companies is set to announce quarterly earnings results over the next few days. Let’s look at a few key trends to watch for in the reports.

  • [By Ethan Ryder]

    H & R Block Inc (NYSE:HRB) Director Robert A. Gerard acquired 1,000 shares of the firm’s stock in a transaction dated Friday, June 22nd. The shares were purchased at an average price of $23.18 per share, for a total transaction of $23,180.00. Following the completion of the transaction, the director now directly owns 148,579 shares in the company, valued at $3,444,061.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Stephan Byrd]

    H&R Block (NYSE:HRB) saw some unusual options trading on Monday. Stock traders purchased 13,239 call options on the company. This represents an increase of approximately 1,694% compared to the average daily volume of 738 call options.

  • [By Joseph Griffin]

    TheStreet upgraded shares of H & R Block (NYSE:HRB) from a c+ rating to a b rating in a report released on Tuesday.

    Other equities research analysts have also issued research reports about the company. Barrington Research lowered their price objective on H & R Block from $32.00 to $27.00 and set an outperform rating for the company in a research note on Thursday. ValuEngine downgraded H & R Block from a sell rating to a strong sell rating in a report on Wednesday. Morgan Stanley reaffirmed an equal weight rating and set a $28.00 target price (up previously from $27.00) on shares of H & R Block in a report on Wednesday, March 7th. BMO Capital Markets reduced their target price on H & R Block from $29.00 to $25.00 and set a market perform rating on the stock in a report on Wednesday. Finally, Zacks Investment Research downgraded H & R Block from a strong-buy rating to a hold rating in a report on Tuesday, March 27th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. H & R Block presently has a consensus rating of Hold and a consensus price target of $26.21.

  • [By Paul Ausick]

    H&R Block Inc. (NYSE: HRB) traded down about 1.2% Tuesday and posted a new 52-week low of $23.28 after closing Monday at $23.55. The stock’s 52-week high is $31.80. Volume totaled about 3.1 million, about a third higher than the daily average of around 3.2 million. The company had no specific news. Shares have turned around and are headed for a gain of about 1.4% at the closing bell.

  • [By Garrett Baldwin]

    Today, Bill offers our readers a few of his favorites as Trump meets with Kim Jong Un.Here’s how to cash in regardless of how this summit turns out in the long run.

    The Top Stock Market Stories for Tuesday
    Last night, President Trump met North Korean leader Kim Jong Un in Singapore. This was the first meeting between a sitting American president and a North Korean leader. Following the agreement, analysts noted that the document signed by both parties included no concrete details for achieving denuclearization on the Korean Peninsula. Trump responded to criticism by saying he is fully confident that the Korean dictatorship will follow through. A U.S. district court will rule on whether to approve an $85 billion merger between AT&T Inc. (NYSE: T) and Time Warner Inc. (NYSE: TWX). The decision comes after about six weeks of debate in a courtroom. The ruling will likely have a significant impact on the proposed bid by The Walt Disney Co. (NYSE: DIS) for media giant Twenty-First Century Fox Inc.(NYSE: FOXA). The Fed Open Market Committee kicks off its June meeting today. The U.S. central bank is expected to raise interest rates for the second time in 2018. On Wednesday, U.S. Federal Reserve Chair Jerome Powell will likely announce a hike of 0.25% to the benchmark rate to 2%. This would also mark the seventh hike since December 2015. Markets will be looking for clues during Powell’s conference to determine how many additional times the Fed plans to raise interest rates during the final six months of the year.
    Three Stocks to Watch Today: RH, TSLA, GE
    Restoration Hardware Holdings Inc. (NYSE: RH) stock popped more than 20% in pre-market hours after the company reported very strong profits for the quarter. The retailer reported earnings per share of $1.33, well above the $1.02 anticipated by analysts. The company also reported a strong second-quarter outlook, news that reduced concerns about it falling short of revenue expectations. Tesla Inc. (Nasdaq: TS

Best Stocks To Buy Right Now: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By ]

    Throughout its history, Starbucks has mostly had a company-owned model for its retail locations, a strategy that is at odds with a trend of activist investors pushing fast food, restaurant and coffee companies to franchise locations out to raise cash for stock buybacks and debt reduction. In recent years, activists have targeted Jamba Juice (JMBA) , Potbelly (PBPB) , Jack in the Box (JACK) , Wendys Co. (WEN) , McDonald’s (MCD) and elsewhere. In addition, Starbucks has a one-share, one-vote structure, which can make it vulnerable to an activist investor seeking to elect dissident director candidates as it pursued the strategy.

  • [By Stephan Byrd]

    Wendys (NASDAQ: WEN) and Empire Resorts (NASDAQ:NYNY) are both retail/wholesale companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

  • [By Logan Wallace]

    Wendy’s (NASDAQ:WEN) major shareholder Edward P. Garden sold 764,000 shares of the business’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $16.53, for a total value of $12,628,920.00. Following the completion of the sale, the insider now directly owns 240,365 shares of the company’s stock, valued at approximately $3,973,233.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

  • [By ]

    In the Lightning Round, Cramer was bullish on Spirit AeroSystems (SPR) , Take-Two Interactive (TTWO) , Dunkin Brands (DNKN) and Wendy’s (WEN) .

    Cramer was bearish on Bristol-Myers Squibb (BMY) and Univar (UNVR) .

  • [By Matt Hogan]

    Growth within the industry is a bit lumpy, with limited-service restaurants, such as Wendys Co (NASDAQ: WEN) and Chipotle Mexican Grill, Inc (NYSE: CMG), growing at 5.3 percent in 2017 as compared to 3.5 percent for casual dining establishments according to the National Restaurant Industry.

  • [By Leo Sun]

    However, the fast casual market became increasingly crowded with rival chains like Panera Bread and Chipotle, and Zoe’s got squeezed between traditional dine-in restaurants like Darden’s Olive Garden and evolving fast food players like Wendy’s (NASDAQ:WEN) and McDonald’s (NYSE:MCD).

Best Stocks To Buy Right Now: U.S. Silica Holdings, Inc.(SLCA)

Advisors’ Opinion:

  • [By Tyler Crowe]

    U.S. Silica Holdings (NYSE:SLCA) has long been the standout company in the frack sand business. Its size and financial strength allowed it to weather the drop in oil prices better than its peers and positioned it well for the recent growth phase. This past quarter, the company expanded its universe by acquiring another mineral mining business, but it is taking some risk in doing this. Thankfully, demand for frack sand remains high, as evidenced by the company’s most recent earnings results.

  • [By Ethan Ryder]

    U.S. Silica (NYSE: SLCA) and Fairmount Santrol (NYSE:FMSA) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.

  • [By Jason Hall, Tyler Crowe, and John Bromels]

    Three Motley Fool energy experts have already put in the work to help you get started, having identified integrated oil and gas super-major Royal Dutch Shell plc (ADR)(NYSE:RDS-A)(NYSE:RDS-B), surprisingly diverse sand supplierU.S. Silica Holdings Inc(NYSE:SLCA), and still-cheap, still-strong wind turbine leaderVestas Wind Systems(NASDAQOTH:VWDRY).Keep reading for unique, real-investor insight on what makes these three energy stocks worth buying this month.